GREAT POINT PARTNERS LLC 13D and 13G filings for Millendo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:13 pm Sale | 2020-12-31 | 13G | Millendo Therapeutics, Inc. MLND | GREAT POINT PARTNERS LLC | 18,000 1.420% | -97,317 (-84.39%) | Filing |